Effect of hypericum perforatum extract in an experimental model of binge eating in female rats

Journal of Obesity

Volumn 2012, Issue , 2012, Pages

  Micioni Di Bonaventura, Maria Vittoria ^a   Vitale, Giovanni ^b   Massi, Maurizio ^a   Cifani, Carlo ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; HYPERICUM PERFORATUM EXTRACT; SALIDROSIDE;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINGE EATING DISORDER; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIET RESTRICTION; FEEDING; FEMALE; NONHUMAN; ODOR; RAT;

EID: 84867322191     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2012/956137     Document Type: Article

References (89)

1. American Psychiatric Association. Diagnostic and statistic manual of mental disorders, IV-TR Washington, 2000
2. Walsh B. T., Devlin M. J., Eating disorders: progress and problems. Science 1998 280 5368 1387 1390 2-s2.0-0032577351 10.1126/science.280.5368.1387 (Pubitemid 28264821)
3. Hudson J. I., Hiripi E., Pope H. G. Jr., Kessler R. C., The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry 2007 61 3 348 358 2-s2.0-33846255478 10.1016/j.biopsych.2006.03.040 (Pubitemid 46108682)
4. Javaras K. N., Pope H. G. Jr., Lalonde J. K., Roberts J. L., Nillni Y. I., Laird N. M., Bulik C. M., Crow S. J., McElroy S. L., Walsh B. T., Tsuang M. T., Rosenthal N. R., Hudson J. I., Co-occurrence of binge eating disorder with psychiatric and medical disorders. Journal of Clinical Psychiatry 2008 69 2 266 273 2-s2.0-41549091416 (Pubitemid 351469270)
5. Grucza R. A., Przybeck T. R., Cloninger C. R., Prevalence and correlates of binge eating disorder in a community sample. Comprehensive Psychiatry 2007 48 2 124 131 2-s2.0-33846784002 10.1016/j.comppsych.2006.08.002 (Pubitemid 46204665)
6. Fassino S., Leombruni P., Pierò A., Abbate-Daga G., Rovera G. G., Mood, eating attitudes, and anger in obese women with and without Binge Eating Disorder. Journal of Psychosomatic Research 2003 54 6 559 566 2-s2.0-0141672076 10.1016/S0022-3999(02)00462-2 (Pubitemid 38367948)
7. Mathes W. F., Brownley K. A., Mo X., Bulik C. M., The biology of binge eating. Appetite 2009 52 3 545 553 2-s2.0-67349231948 10.1016/j.appet.2009.03. 005
8. Heath A. C., Binge-eating and bulimia: potential insights into etiology and pathophysiology through genetic epidemiologic studies. Biological Psychiatry 1998 44 12 1208 1209 2-s2.0-0032534968 10.1016/S0006-3223(98)00327-8 (Pubitemid 29015859)
9. Devlin M. J., Yanovski S. Z., Wilson G. T., Obesity: what mental health professionals need to know. American Journal of Psychiatry 2000 157 6 854 866 2-s2.0-0034047295 10.1176/appi.ajp.157.6.854 (Pubitemid 30412334)
10. Yanovski S. Z., Binge eating disorder and obesity in 2003: could treating an eating disorder have a positive effect on the obesity epidemic? International Journal of Eating Disorders 2003 34 supplement S117 S120 2-s2.0-0041707905 10.1002/eat.10211 (Pubitemid 36935719)
11. Wardle J., Steptoe A., Oliver G., Lipsey Z., Stress, dietary restraint and food intake. Journal of Psychosomatic Research 2000 48 2 195 202 2-s2.0-0034034473 10.1016/S0022-3999(00)00076-3 (Pubitemid 30200947)
12. Freeman L. M. Y., Gil K. M., Daily stress, coping, and dietary restraint in binge eating. International Journal of Eating Disorders 2004 36 2 204 212 2-s2.0-4143119090 10.1002/eat.20012 (Pubitemid 39095270)
13. Polivy J., Zeitlin S. B., Herman C. P., Beal A. L., Food restriction and binge eating: a study of former prisoners of war. Journal of Abnormal Psychology 1994 103 2 409 411 2-s2.0-0028240728 10.1037/0021-843X.103.2.409 (Pubitemid 24152817)
14. Wong J. C. H., Lewindon P., Mortimer R., Shepherd R., Internal and external antecedents of binge eating episodes in a group of women with bulimia nervosa. International Journal of Eating Disorders 2001 29 1 17 22 2-s2.0-0035169124 10.1002/1098-108X(200101)29:117::AID-EAT3>3.0.CO;2-R (Pubitemid 32046964)
15. Stice E., Agras W. S., Telch C. F., Halmi K. A., Mitchell J. E., Wilson T., Subtyping binge eating-disordered women along dieting and negative affect dimensions. International Journal of Eating Disorders 2001 30 1 11 27 2-s2.0-0034990184 10.1002/eat.1050 (Pubitemid 32500215)
16. Crowther J. H., Sanftner J., Bonifazi D. Z., Shepherd K. L., The role of daily hassles in binge eating. International Journal of Eating Disorders 2001 29 4 449 454 2-s2.0-0035075974 10.1002/eat.1041 (Pubitemid 32295636)
17. Wolff G. E., Crosby R. D., Roberts J. A., Wittrock D. A., Differences in daily stress, mood, coping, and eating behavior in binge eating and nonbinge eating college women. Addictive Behaviors 2000 25 2 205 216 2-s2.0-0034004252 10.1016/S0306-4603(99)00049-0 (Pubitemid 30114240)
18. National Institute for Clinical Excellence, Eating disorders-core interventions in the treatment and management of anorexia nervosa, bulimia nervosa, and related eating disorders. NICE Clinical Guideline no 2004 9 London, UK NICE
19. McElroy S. L., Shapira N. A., Arnold L. M., Keck P. E. Jr., Rosenthal N. R., Wu S. C., Capece J. A., Fazzio L., Hudson J. I., Topiramate in the long-term treatment of binge-eating disorder associated with obesity. Journal of Clinical Psychiatry 2004 65 11 1463 1469 2-s2.0-16544363331 10.4088/JCP.v65n1104
20. McElroy S. L., Hudson J. I., Capece J. A., Beyers K., Fisher A. C., Rosenthal N. R., Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biological Psychiatry 2007 61 9 1039 1048 2-s2.0-33947728065 10.1016/j.biopsych.2006.08.008 (Pubitemid 46551975)
21. Appolinario J. C., Godoy-Matos A., Fontenelle L. F., Carraro L., Cabral M., Vieira A., Coutinho W., An open-label trial of sibutramine in obese patients with binge-eating disorder. Journal of Clinical Psychiatry 2002 63 1 28 30 2-s2.0-0036154730 (Pubitemid 34113483)
22. Wilfley D. E., Crow S. J., Hudson J. I., Mitchell J. E., Berkowitz R. I., Blakesley V., Walsh B. T., Alger-Mayer S., Bartlett S., Fernstrom M., Foreyt J., Fujioka K., Halmi K., Harrison R. W., Gerich J., Johnson W., Lilenfeld L., Pearlstein T., Perri M. G., Robbins D., Smith-West D., Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study. American Journal of Psychiatry 2008 165 1 51 58 2-s2.0-39049142876 10.1176/appi.ajp.2007.06121970 (Pubitemid 351704552)
23. McElroy S. L., Guerdjikova A. I., Martens B., Keck P. E. Jr., Pope H. G. Jr., Hudson J. I., Role of antiepileptic drugs in the management of eating disorders. CNS Drugs 2009 23 2 139 156 2-s2.0-59149087853 10.2165/00023210- 200923020-00004
24. Carter W. P., Hudson J. I., Lalonde J. K., Pindyck L., McElroy S. L., Pope H. G. Jr., Pharmacologic treatment of binge eating disorder. International Journal of Eating Disorders 2003 34 supplement S74 S88 2-s2.0-0041989812 10.1002/eat.10207 (Pubitemid 36935715)
25. Yager J., Binge eating disorder: the search for better treatments. American Journal of Psychiatry 2008 165 1 4 6 2-s2.0-39049172714 10.1176/appi.ajp.2007.07101541 (Pubitemid 351704542)
26. DRUGDEX System [Internet Database] 2010 Greenwood Village, Colo, USA Thomson Reuters (Healthcare)
27. Gold M. S., Frost-Pineda K., Jacobs W. S., Overeating, binge eating, and eating disorders as addictions. Psychiatric Annals 2003 33 2 117 122 2-s2.0-2042510349 (Pubitemid 38535126)
28. Pelchat M. L., Johnson A., Chan R., Valdez J., Ragland J. D., Images of desire: food-craving activation during fMRI. NeuroImage 2004 23 4 1486 1493 2-s2.0-13844317753 10.1016/j.neuroimage.2004.08.023 (Pubitemid 40260371)
29. Avena N. M., Rada P., Hoebel B. G., Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neuroscience and Biobehavioral Reviews 2008 32 1 20 39 2-s2.0-36348989627 10.1016/j.neubiorev.2007.04.019 (Pubitemid 350160955)
30. Ifland J. R., Preuss H. G., Marcus M. T., Rourke K. M., Taylor W. C., Burau K., Jacobs W. S., Kadish W., Manso G., Refined food addiction: a classic substance use disorder. Medical Hypotheses 2009 72 5 518 526 2-s2.0-61349158507 10.1016/j.mehy.2008.11.035
31. Gearhardt A. N., Corbin W. R., Brownell K. D., Food addiction: an examination of the diagnostic criteria for dependence. Journal of Addiction Medicine 2009 3 1 1 7 2-s2.0-70349241894 10.1097/ADM.0b013e318193c993
32. Hoebel B. G., Brain neurotransmitters in food and drug reward. American Journal of Clinical Nutrition 1985 42 5 1133 1150 2-s2.0-0022338218 (Pubitemid 16148065)
33. Volkow N. D., Wise R. A., How can drug addiction help us understand obesity? Nature Neuroscience 2005 8 5 555 560 2-s2.0-17844398708 10.1038/nn1452 (Pubitemid 40594193)
34. Corwin R. L., Avena N. M., Boggiano M. M., Feeding and reward: perspectives from three rat models of binge eating. Physiology and Behavior 2011 104 1 87 97 2-s2.0-79957628450 10.1016/j.physbeh.2011.04.041
35. Gearhardt A. N., Yokum S., Orr P. T., Stice E., Corbin W. R., Brownell K. D., Neural correlates of food addiction. Archives of General Psychiatry 2011 68 8 808 816 2-s2.0-79957633261 10.1001/archgenpsychiatry.2011.32
36. Wang G. J., Geliebter A., Volkow N. D., Telang F. W., Logan J., Jayne M. C., Galanti K., Selig P. A., Han H., Zhu W., Wong C. T., Fowler J. S., Enhanced striatal dopamine release during food stimulation in binge eating disorder. Obesity 2011 19 8 1601 1608 2-s2.0-79960847597 10.1038/oby.2011.27
37. Boggiano M. M., Chandler P. C., Viana J. B., Oswald K. D., Maldonado C. R., Wauford P. K., Combined dieting and stress evoke exaggerated responses to opioids in binge-eating rats. Behavioral Neuroscience 2005 119 5 1207 1214 2-s2.0-27744447232 10.1037/0735-7044.119.5.1207 (Pubitemid 41598733)
38. Buda-Levin A., Wojnicki F. H. E., Corwin R. L., Baclofen reduces fat intake under binge-type conditions. Physiology and Behavior 2005 86 1-2 176 184 2-s2.0-24944563848 10.1016/j.physbeh.2005.07.020 (Pubitemid 41316622)
39. Corwin R. L., Wojnicki F. H., Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions. Behavioural Pharmacology 2009 20 5-6 537 548 2-s2.0-70349683205 10.1097/FBP.0b013e3283313168
40. Cifani C., Polidori C., Melotto S., Ciccocioppo R., Massi M., A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam. Psychopharmacology 2009 204 1 113 125 2-s2.0-67349091024 10.1007/s00213-008- 1442-y
41. Broft A. I., Spanos A., Corwin R. L., Mayer L., Steinglass J., Devlin M. J., Attia E., Walsh B. T., Baclofen for binge eating: an open-label trial. International Journal of Eating Disorders 2007 40 8 687 691 2-s2.0-36148971274 10.1002/eat.20434 (Pubitemid 350106957)
42. Meyer F., Alleviation of both binge eating and sexual dysfunction with naltrexone. Journal of Clinical Psychopharmacology 2008 28 6 722 723 2-s2.0-59049106843 10.1097/JCP.0b013e31818d6d26
43. Arbaizar B., Gómez-Acebo I., Llorca J., Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review. General Hospital Psychiatry 2008 30 5 471 475 2-s2.0-50949106351 10.1016/j.genhosppsych.2008.02. 002
44. Perfumi M., Ciccocioppo R., Angeletti S., Cucculelli M., Massi M., Effects of Hypericum perforatum extract on alcohol intake in Marchigian Sardinian alcohol-preferring rats. Alcohol and Alcoholism 1999 34 5 690 698 2-s2.0-0032880931 10.1093/alcalc/34.5.690 (Pubitemid 29467060)
45. Perfumi M., Ciccocioppo R., Angeletti S., Cucculelli M., Massi M., Effects of Hypericum perforatum extract on alcohol intake in Marchigtan Sardinian alcohol-preferring rats. Alcohol and Alcoholism 1999 34 5 690 698 2-s2.0-0032880931 10.1093/alcalc/34.5.690 (Pubitemid 29467060)
46. Panocka I., Perfumi M., Angeletti S., Ciccocioppo R., Massi M., Effects of Hypericum perforatum extract on ethanol intake, and on behavioral despaira search for the neurochemical systems involved. Pharmacology Biochemistry and Behavior 2000 66 1 105 111 2-s2.0-0034105176 10.1016/S0091-3057(00)00193-3 (Pubitemid 30317523)
47. 2-extract and opioid receptor antagonists act synergistically to reduce ethanol intake in alcohol-preferring rats. Alcoholism 2003 27 10 1554 1562 2-s2.0-0041302904 10.1097/01.ALC.0000092062. 60924.56 (Pubitemid 37280737)
48. Rezvani A. H., Overstreet D. H., Perfumi M., Massi M., Plant derivatives in the treatment of alcohol dependency. Pharmacology Biochemistry and Behavior 2003 75 3 593 606 2-s2.0-0041696926 10.1016/S0091-3057(03)00124-2 (Pubitemid 36936894)
49. Overstreet D. H., Keung W. M., Rezvani A. H., Massi M., Lee D. Y. W., Herbal remedies for alcoholism: promises and possible pitfalls. Alcoholism 2003 27 2 177 185 2-s2.0-0037323973 10.1097/01.ALC.0000051022.26489.CF (Pubitemid 36236641)
50. 2 extract on the motivational properties of ethanol in alcohol-preferring rats. Alcohol and Alcoholism 2005 40 4 291 296 2-s2.0-21244482057 10.1093/alcalc/agh133 (Pubitemid 40895425)
51. Barnes J., Anderson L. A., Phillipson J. D., St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. Journal of Pharmacy and Pharmacology 2001 53 5 583 600 2-s2.0-0034998557 10.1211/0022357011775910 (Pubitemid 32457809)
52. Loakmann G., St. John's Wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 1998 31 1 54 59 2-s2.0-0031747773
53. Linde K., Mulrow C. D., St John's wort for depression. Cochrane Database of Systematic Reviews 2000 2 CD000448 2-s2.0-0033656826
54. Volz H. P., Controlled clinical trials of hypericum extracts in depressed patientsan overview. Pharmacopsychiatry 1997 30 2 72 76 2-s2.0-0030770886
55. Vormfelde S. V., Poser W., Gaster B., Hyperforin in extracts of St John's wort (Hypericum perforatum) for depression. Archives of Internal Medicine 2000 160 16 2548 2549 2-s2.0-0034637999
56. Butterweck V., Effects of the total extract and fractions of hyper/cum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry 1997 30 2 117 124 2-s2.0-0030821595
57. Chatterjee S. S., Bhattacharya S. K., Wonnemann M., Singer A., Müller W. E., Hyperforin as a possible antidepressant component of hypericum extracts. Life Sciences 1998 63 6 499 510 2-s2.0-0032479206 10.1016/S0024-3205(98)00299-9 (Pubitemid 28367402)
58. Gambarana C., Ghiglieri O., Tolu P., De M. G., Giachetti D., Bombardelli E., Tagliamonte A., Efficacy of an Hypericum perforatum (St. John's Wort) extract in preventing and reverting a condition of escape deficit in rats. Neuropsychopharmacology 1999 21 2 247 257 2-s2.0-0033013398 10.1016/S0893- 133X(99)00027-5 (Pubitemid 29304586)
59. Gambarana C., Tolu P. L., Masi F., Rinaldi M., Giachetti D., Morazzoni P., De Montis M. G., A study of the antidepressant activity of Hypericum perforatum on animal models. Pharmacopsychiatry 2001 34 1 S42 S44 2-s2.0-0034914934
60. Nathan P. J., The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.). Molecular Psychiatry 1999 4 4 333 338 2-s2.0-0032824062 (Pubitemid 29440572)
61. 2 extract of hypericum perforatum on alcohol intake in rats. Alcohol and Alcoholism 2001 36 3 199 206 2-s2.0-0034991042 (Pubitemid 32519853)
62. Nahrstedt A., Biologically active and other chemical constituents of the herb of Hypericum perforation L. Pharmacopsychiatry 1997 30 2 129 134 2-s2.0-0030874985
63. Jensen A. G., Hansen S. H., Nielsen E. O., Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity. Life Sciences 2001 68 14 1593 1605 2-s2.0-0035936726 10.1016/S0024-3205(01)00946-8 (Pubitemid 32248716)
64. Wirz A., Simmen U., Heilmann J., alis I., Meier B., Sticher O., Bisanthraquinone glycosides of Hypericum perforatum with binding inhibition to CRH-1 receptors. Phytochemistry 2000 55 8 941 947 2-s2.0-0034642222 10.1016/S0031-9422(00)00305-8
65. Simmen U., Higelin J., Berger-Büter K., Schaffner W., Lundstrom K., Neurochemical studies with St. John's wort in vitro. Pharmacopsychiatry 2001 34 supplement 1 S137 S142 2-s2.0-0034921163
66. Simmen U., Bobirnac I., Ullmer C., Lübbert H., Berger Büter K., Schaffner W., Schoeffter P., Antagonist effect of pseudohypericin at CRF1 receptors. European Journal of Pharmacology 2003 458 3 251 256 2-s2.0-0347298809 10.1016/S0014-2999(02)02818-2 (Pubitemid 36009464)
67. Roos G., Röseler C., Büter K. B., Simmen U., Classification and correlation of St. John's wort extracts by nuclear magnetic resonance spectroscopy, multivariate data analysis and pharmacological activity. Planta Medica 2004 70 8 771 777 2-s2.0-4444364508 10.1055/s-2004-827210 (Pubitemid 39178940)
68. Butterweck V., Hegger M., Winterhoff H., Flavonoids of St. John's Wort reduce HPA axis function in the rat. Planta Medica 2004 70 10 1008 1011 2-s2.0-7644232422 10.1055/s-2004-832631 (Pubitemid 39457815)
69. Grundmann O., Lv Y., Kelber O., Butterweck V., Mechanism of St. John's wort extract (STW3-VI) during chronic restraint stress is mediated by the interrelationship of the immune, oxidative defense, and neuroendocrine system. Neuropharmacology 2010 58 4-5 767 773 2-s2.0-77649336139 10.1016/j.neuropharm. 2009.12.014
70. Crupi R., Mazzon E., Marino A., La Spada G., Bramanti P., Battaglia F., Cuzzocrea S., Spina E., Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice. BMC Complementary and Alternative Medicine 2011 11, article 7 2-s2.0-79251553447 10.1186/1472-6882-11- 7
71. Panossian A., Wagner H., Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. Phytotherapy Research 2005 19 10 819 838 2-s2.0-27944504357 10.1002/ptr.1751 (Pubitemid 41670526)
72. Panossian A., Wikman G., Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Current Clinical Pharmacology 2009 4 3 198 219 2-s2.0-70549106478 10.2174/157488409789375311
73. Cifani C., Micioni Di M. V., Vitale G., Ruggieri V., Ciccocioppo R., Massi M., Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating. Physiology and Behavior 2010 101 5 555 562 2-s2.0-78149268898 10.1016/j.physbeh.2010.09.006
74. Hagan M. M., Wauford P. K., Chandler P. C., Jarrett L. A., Rybak R. J., Blackburn K., A new animal model of binge eating: key synergistic role of past caloric restriction and stress. Physiology and Behavior 2002 77 1 45 54 2-s2.0-0036709789 10.1016/S0031-9384(02)00809-0 (Pubitemid 35245719)
75. 2 extract of Hypericum perforatum on alcohol intake in rats. Alcohol and Alcoholism 2001 36 3 199 206 2-s2.0-0034991042 (Pubitemid 32519853)
76. Micioni Di B. M. V., Cifani C., Ciccocioppo R., Massi M., Influence of the ovarian cycle on binge eating evoked in female rats by stress and food restrictions. Appetite 2010 54, article 663
77. Akana S. F., Cascio C. S., Du J. Z., Reset of feedback in the adrenocortical system: an apparent shift in sensitivity of adrenocorticotropin to inhibition by corticosterone between morning and evening. Endocrinology 1986 119 5 2325 2332 2-s2.0-0023005752 (Pubitemid 17171420)
78. Vitale G., Arletti R., Ruggieri V., Cifani C., Massi M., Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats. Peptides 2006 27 9 2193 2200 2-s2.0-33746892640 10.1016/j.peptides.2006.04.003 (Pubitemid 44189629)
79. Piazza P. V., Deroche V., Deminiere J. M., Maccari S., Le Moal M., Simon H., Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. Proceedings of the National Academy of Sciences of the United States of America 1993 90 24 11738 11742 2-s2.0-0027136186 10.1073/pnas.90.24.11738 (Pubitemid 24008714)
80. Dellu F., Piazza P. V., Mayo W., Le Moal M., Simon H., Novelty-seeking in rats biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology 1996 34 3 136 145 2-s2.0-0029952921 (Pubitemid 26355758)
81. Mantsch J. R., Saphier D., Goeders N. E., Corticosterone facilitates the acquisition of cocaine self- administration in rats: opposite effects of the type II glucocorticoid receptor agonist dexamethasone. Journal of Pharmacology and Experimental Therapeutics 1998 287 1 72 80 2-s2.0-0032463958 (Pubitemid 29140188)
82. Shalev U., Marinelli M., Baumann M. H., Piazza P. V., Shaham Y., The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat. Psychopharmacology 2003 168 1-2 170 176 2-s2.0-0037488172 10.1007/s00213-002-1200-5 (Pubitemid 36851176)
83. Micioni Di B. M. V., Cifani C., Rice K. C., Ciccocioppo R., Massi M., Effect of the CRF-1 receptor antagonist R121919 on binge eating. Appetite 2011 57S, article S30
84. Koob G. F., A role for brain stress system in addiction. Neuron 2008 59 1 11 34 2-s2.0-46149120544 10.1016/j.neuron.2008.06.012 (Pubitemid 351905857)
85. Ciccocioppo R., Economidou D., Cippitelli A., Cucculelli M., Ubaldi M., Soverchia L., Lourdusamy A., Massi M., Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addiction Biology 2006 11 3-4 339 355 2-s2.0-33750055822 10.1111/j.1369-1600.2006.00032.x (Pubitemid 46696907)
86. Butterweck V., Winterhoff H., Herkenham M., Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats. Neuropsychopharmacology 2003 28 12 2160 2168 2-s2.0-0344552955 (Pubitemid 37468183)
87. Panossian A., Wikman G., Kaur P., Asea A., Adaptogens stimulate neuropeptidey and Hsp72 expression and release in neuroglia cells. Frontiers in Neuroscience 2012 6, article 6 2-s2.0-84862186276 10.3389/fnins.2012.00006
88. Ammar A. A., Nergårdh R., Fredholm B. B., Brodin U., Södersten P., Intake inhibition by NPY and CCK-8: a challenge of the notion of NPY as an 'orexigen' Behavioural Brain Research 2005 161 1 82 87 2-s2.0-19344363690 10.1016/j.bbr.2005.01.014 (Pubitemid 40719773)
89. Sederholm F., Ammar A. A., Södersten P., Intake inhibition by NPY: role of appetitive ingestive behavior and aversion. Physiology and Behavior 2002 75 4 567 575 2-s2.0-0036534644 10.1016/S0031-9384(02)00648-0 (Pubitemid 34327964)